Literature DB >> 23768870

Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis.

Klaus Munkholm1, Julie Vestergaard Braüner, Lars Vedel Kessing, Maj Vinberg.   

Abstract

BACKGROUND: Bipolar disorder may be associated with peripheral immune system dysfunction; however, results in individual studies are conflicting. Our aim was to systematically review evidence of peripheral cytokine alterations in bipolar disorder integrating findings from various affective states.
METHODS: We conducted a meta-analysis of studies comparing peripheral cytokine concentrations in patients with bipolar disorder with healthy control subjects. Results were reported according to the PRISMA statement.
RESULTS: Eighteen studies with a total of 761 bipolar disorder patients and 919 healthy controls were included. Overall, concentrations of soluble Interleukin (IL)-2 receptor (sIL-2R), tumor necrosis factor-α (TNF-α), soluble tumor necrosis factor receptor type 1 (sTNFR1) (p < 0.001 each), sIL-6R (p = 0.01) and IL-4 (p = 0.04) were significantly higher in bipolar patients compared with healthy controls. There were no significant differences between bipolar disorder patients and healthy control subjects for IL-1, IL-2, IL-5, IL-6, IL-8, IL-10, IL-12, IL-1β, IL-1 receptor antagonist (IL-1RA), interferon-γ (IFN-γ), transforming growth factor-β1 (TGF-β1) and sTNFR2.
CONCLUSIONS: Employing a global approach, incorporating evidence across affective states, this meta-analysis found some support for peripheral inflammatory alterations in bipolar disorder. Results were limited by heterogeneity between studies, insufficient standardization and lacking control for confounders in individual studies. Further research exploring the role of the peripheral inflammatory system in relation to neuroinflammation is warranted.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biomarker; Bipolar disorder; Cytokines; Inflammation; Meta-analysis; Review

Mesh:

Substances:

Year:  2013        PMID: 23768870     DOI: 10.1016/j.jpsychires.2013.05.018

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  102 in total

1.  A Study of TNF Pathway Activation in Schizophrenia and Bipolar Disorder in Plasma and Brain Tissue.

Authors:  Eva Zsuzsanna Hoseth; Thor Ueland; Ingrid Dieset; Rebecca Birnbaum; Joo Heon Shin; Joel Edward Kleinman; Thomas Michael Hyde; Ragni Helene Mørch; Sigrun Hope; Tove Lekva; Aurelija Judita Abraityte; Annika E Michelsen; Ingrid Melle; Lars Tjelta Westlye; Torill Ueland; Srdjan Djurovic; Pål Aukrust; Daniel R Weinberger; Ole Andreas Andreassen
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

2.  Neuroinflammation in psychiatric disorders: An introductory primer.

Authors:  Geoffrey A Dunn; Jennifer M Loftis; Elinor L Sullivan
Journal:  Pharmacol Biochem Behav       Date:  2020-07-01       Impact factor: 3.533

3.  Anhedonia as a clinical correlate of inflammation in adolescents across psychiatric conditions.

Authors:  Rachel D Freed; Lushna M Mehra; Daniel Laor; Manishkumar Patel; Carmen M Alonso; Seunghee Kim-Schulze; Vilma Gabbay
Journal:  World J Biol Psychiatry       Date:  2018-08-16       Impact factor: 4.132

4.  Associations of Serum Cytokine Receptor Levels with Melancholia, Staging of Illness, Depressive and Manic Phases, and Severity of Depression in Bipolar Disorder.

Authors:  Marcin Siwek; Magdalena Sowa-Kućma; Krzysztof Styczeń; Paulina Misztak; Rafał J Nowak; Bernadeta Szewczyk; Dominika Dudek; Janusz K Rybakowski; Gabriel Nowak; Michael Maes
Journal:  Mol Neurobiol       Date:  2016-09-23       Impact factor: 5.590

5.  Monocyte and microglial activation in patients with mood-stabilized bipolar disorder.

Authors:  Joel Jakobsson; Maria Bjerke; Sara Sahebi; Anniella Isgren; Carl Johan Ekman; Carl Sellgren; Bob Olsson; Henrik Zetterberg; Kaj Blennow; Erik Pålsson; Mikael Landén
Journal:  J Psychiatry Neurosci       Date:  2015-07       Impact factor: 6.186

Review 6.  The immunology of bipolar disorder.

Authors:  Izabela Guimarães Barbosa; Rodrigo Machado-Vieira; Jair C Soares; Antonio L Teixeira
Journal:  Neuroimmunomodulation       Date:  2014-02-14       Impact factor: 2.492

Review 7.  Intracellular Signaling Cascades in Bipolar Disorder.

Authors:  Gregory H Jones; Carola Rong; Aisha S Shariq; Abhinav Mishra; Rodrigo Machado-Vieira
Journal:  Curr Top Behav Neurosci       Date:  2021

Review 8.  Effects of lithium on inflammation.

Authors:  Ahmad Nassar; Abed N Azab
Journal:  ACS Chem Neurosci       Date:  2014-05-06       Impact factor: 4.418

9.  Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress.

Authors:  Qian Ren; Min Ma; Tamaki Ishima; Christophe Morisseau; Jun Yang; Karen M Wagner; Ji-Chun Zhang; Chun Yang; Wei Yao; Chao Dong; Mei Han; Bruce D Hammock; Kenji Hashimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-14       Impact factor: 11.205

10.  Abnormal gene expression of proinflammatory cytokines and their receptors in the lymphocytes of patients with bipolar disorder.

Authors:  Ghanshyam N Pandey; Xinguo Ren; Hooriyah S Rizavi; Hui Zhang
Journal:  Bipolar Disord       Date:  2015-08-08       Impact factor: 6.744

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.